IFITM5基因5'-非翻译区的复发性突变导致V型成骨不全。 - Suppr

Suppr

超能文献

A recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.

作者信息

Takagi Masaki, Sato Shuhei, Hara Keiichi, Tani Chihiro, Miyazaki Osamu, Nishimura Gen, Hasegawa Tomonobu

机构信息

Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

出版信息

Am J Med Genet A. 2013 Aug;161A(8):1980-2. doi: 10.1002/ajmg.a.36025. Epub 2013 Jun 27.

DOI:10.1002/ajmg.a.36025

PMID:23813632

Abstract

摘要

相似文献

A recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.IFITM5基因5'-非翻译区的复发性突变导致V型成骨不全。

Am J Med Genet A. 2013 Aug;161A(8):1980-2. doi: 10.1002/ajmg.a.36025. Epub 2013 Jun 27.

A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.IFITM5 5'-UTR 中的单个反复突变导致成骨不全症 V 型。

Am J Hum Genet. 2012 Aug 10;91(2):343-8. doi: 10.1016/j.ajhg.2012.06.005. Epub 2012 Aug 2.

IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients.IFITM5 致病变异导致乌克兰和越南患者的成骨不全 V 型，其表型严重程度不同。

Hum Genomics. 2019 Jun 3;13(1):25. doi: 10.1186/s40246-019-0209-3.

Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation.由 IFITM5 突变引起的成骨不全症 V 型的表型变异。

J Bone Miner Res. 2013 Jul;28(7):1523-30. doi: 10.1002/jbmr.1891.

A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.IFITM5 5'-UTR 中的突变产生一个无义移码并导致常染色体显性遗传性骨发育不全 V 型伴骨痂过度增生。

Am J Hum Genet. 2012 Aug 10;91(2):349-57. doi: 10.1016/j.ajhg.2012.06.011. Epub 2012 Aug 2.

The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V.IFITM5基因的c.-14C>T突变导致在人骨中表达的转录本延长；并引起V型成骨不全症不同程度的表型严重程度。

BMC Musculoskelet Disord. 2014 Mar 27;15:107. doi: 10.1186/1471-2474-15-107.

Osteogenesis imperfecta type V: clinical and radiographic manifestations in mutation confirmed patients.成骨不全症 V 型：突变确认患者的临床和影像学表现。

Am J Med Genet A. 2013 Aug;161A(8):1972-9. doi: 10.1002/ajmg.a.36024. Epub 2013 Jun 26.

IFITM5 mutations and osteogenesis imperfecta.干扰素诱导跨膜蛋白5（IFITM5）突变与成骨不全症

J Bone Miner Metab. 2016 Mar;34(2):123-31. doi: 10.1007/s00774-015-0667-1. Epub 2015 Jun 2.

Genotype-phenotype study in type V osteogenesis imperfecta.V型成骨不全症的基因型-表型研究

Clin Dysmorphol. 2013 Jul;22(3):93-101. doi: 10.1097/MCD.0b013e32836032f0.

Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.由 IFITM5 基因突变引起的无 V 型特征的成骨不全症。

J Bone Miner Res. 2013 Nov;28(11):2333-7. doi: 10.1002/jbmr.1983.

引用本文的文献

The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect.V型成骨不全症中的IFITM5突变与ERK/SOX9依赖的骨祖细胞分化缺陷相关。

J Clin Invest. 2024 Jun 17;134(15):e170369. doi: 10.1172/JCI170369.

Does the c.-14C>T Mutation in the IFITM5 Gene Provide Identical Phenotypes for Osteogenesis Imperfecta Type V? Data from Russia and a Literature Review.IFITM5基因中c.-14C>T突变是否会导致相同的Ⅴ型成骨不全表型？来自俄罗斯的数据及文献综述。

Biomedicines. 2022 Sep 22;10(10):2363. doi: 10.3390/biomedicines10102363.

Osteogenesis Imperfecta: Search for Mutations in Patients from the Republic of Bashkortostan (Russia).成骨不全症：在俄罗斯巴什科尔托斯坦共和国（俄罗斯）患者中寻找突变。

Genes (Basel). 2022 Jan 10;13(1):124. doi: 10.3390/genes13010124.

Effect of immunosuppressants on a mouse model of osteogenesis imperfecta type V harboring a heterozygous Ifitm5 c.-14C > T mutation.免疫抑制剂对携带杂合性 Ifitm5 c.-14C > T 突变的 V 型成骨不全症小鼠模型的影响。

Sci Rep. 2020 Dec 3;10(1):21197. doi: 10.1038/s41598-020-78403-1.

Expanding the Clinical Spectrum of Osteogenesis Imperfecta Type V: 13 Additional Patients and Review.扩大Ⅴ型成骨不全症的临床谱：新增13例患者及文献复习

Front Endocrinol (Lausanne). 2019 Jun 12;10:375. doi: 10.3389/fendo.2019.00375. eCollection 2019.

PHENOTYPIC VARIABILITY IN INDIVIDUALS WITH TYPE V OSTEOGENESIS IMPERFECTA WITH IDENTICAL IFITM5 MUTATIONS.具有相同IFITM5突变的V型成骨不全症个体的表型变异性。

J Rare Disord. 2013 Dec;1(2):37-42.

Pharmacological and biological therapeutic strategies for osteogenesis imperfecta.成骨不全症的药理和生物治疗策略。

Am J Med Genet C Semin Med Genet. 2016 Dec;172(4):367-383. doi: 10.1002/ajmg.c.31532. Epub 2016 Nov 3.

Clinical and Molecular Characterization of Osteogenesis Imperfecta Type V.成骨不全Ⅴ型的临床与分子特征

Mol Syndromol. 2015 Oct;6(4):164-72. doi: 10.1159/000439506. Epub 2015 Sep 3.

IFITM5 mutations and osteogenesis imperfecta.干扰素诱导跨膜蛋白5（IFITM5）突变与成骨不全症

J Bone Miner Metab. 2016 Mar;34(2):123-31. doi: 10.1007/s00774-015-0667-1. Epub 2015 Jun 2.

A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation.V型成骨不全的转基因小鼠模型支持IFITM5突变的新功能机制。

J Bone Miner Res. 2015 Mar;30(3):489-98. doi: 10.1002/jbmr.2363.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验